This Bristol-Myers Squibb Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Barclays analyst Carter Gould downgraded the rating for Bristol-Myers Squibb Company BMY from Equal-Weight to Underweight and maintained the price target of $41. Bristol-Myers Squibb shares gained 11.4% to settle at $50.45 on Friday. See how other analysts view this stock. See how other analysts view this stock.
Deutsche Bank analyst Scott Deuschle downgraded General Dynamics Corporation GD from Buy to Hold and maintained the price target of $320. General Dynamics shares fell 0.2% to close at $290.40 on Friday. See how other analysts view this stock.
Guggenheim analyst John Difucci downgraded the rating for Fortinet, Inc. FTNT from Buy to Neutral. Fortinet shares fell 0.5% to close at $57.00 on Friday. See how other analysts view this stock.
Piper Sandler analyst Patrick Moley downgraded The Charles Schwab Corporation SCHW from Overweight to Neutral, while cutting the price target from $80 to $64. Charles Schwab shares rose 0.5% to close at $66.60 on Friday. See how other analysts view this stock.
B of A Securities analyst Jeffrey Spector downgraded the rating for Alexandria Real Estate Equities, Inc ARE from Buy to Neutral, while lowering the price target from $151 to $126. Alexandria Real Estate shares gained 2.5% to close at $118.92 on Friday. See how other analysts view this stock.